Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model
Kazuhiro Okumura(Tenri Hospital), Yuichi Wakabayashi(Chiba Cancer Center), Megumi Saito(Chiba Cancer Center), Yurika Tokunaga(Chiba Institute of Science), Eriko Isogai(National Center of Neurology and Psychiatry), Takao Morinaga(Chiba Cancer Center), Masahito Kawazu(Chiba Cancer Center), Yosuke Togashi(Okayama University), Sora Tanaka(Chiba Cancer Center), Keisuke Otoyama(Chiba Cancer Center), Yoshinori Hasegawa(Kazusa DNA Research Institute)
Cited by 3
Related Papers
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
|Cancer Cell|2022|828
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
|Nature Immunology|2020|810
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
|Annals of Oncology|2017|294
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer
|Science Immunology|2020|285